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Magnetic Resonance Imaging–Based Grading
of Cartilaginous Bone Tumors
Added Value of Quantitative Texture Analysis
Benjamin Fritz, MD,*† Daniel A. Müller, MD,†‡ Reto Sutter, MD,*† Moritz C. Wurnig, MD, MSc,†§
Matthias W. Wagner, MD,†§ Christian W.A. Pfirrmann, MD, MBA,*† and Michael A. Fischer, MD*†
Objectives: The aim of this study was to assess the interreader agreement and di-
agnostic accuracy of morphologic magnetic resonance imaging (MRI) analysis
and quantitative MRI-based texture analysis (TA) for grading of cartilaginous
bone tumors.
Materials and Methods: This retrospective study was approved by our local
ethics committee. Magnetic resonance imaging scans of 116 cartilaginous bone
neoplasms were included (53 chondromas, 26 low-grade chondrosarcomas, 37
high-grade chondrosarcomas). Two musculoskeletal radiologists blinded to pa-
tient data separately analyzed 14 morphologic MRI features consisting of tumor
and peritumoral characteristics. In addition, 2 different musculoskeletal radiolo-
gists separately performed TA including 19 quantitative TA parameters in a sim-
ilar fashion. Interreader reliability, univariate, multivariate, and receiver operating
characteristics analyses were performed for MRI and TA parameters separately
and for combined models to determine independent predictors and diagnostic ac-
curacy for grading of cartilaginous neoplasms. P values of 0.05 and less were
considered statistically significant.
Results:Between both readers,MRI and TA features showed a mean kappa value
of 0.49 (range, 0.08–0.82) and a mean intraclass correlation coefficient of 0.79
(range, 0.43–0.99), respectively. Independent morphological MRI predictors for
grading of cartilaginous neoplasms were bone marrow edema, soft tissue mass,
maximum tumor extent, and active periostitis, whereas TA predictors consisted
of short-run high gray-level emphasis, skewness, and gray-level and run-length
nonuniformity. Diagnostic accuracies for differentiation of benign from malig-
nant as well as for benign from low-grade cartilaginous lesions were 87.0% and
77.4% using MRI predictors exclusively, 89.8% and 89.5% using TA predic-
tors exclusively, and 92.9% and 91.2% using a combined model of MRI and
TA predictors, respectively. For differentiation of low-grade from high-grade
chondrosarcoma, no statistically significant independent TA predictors existed,
whereas a model containing MRI predictors exclusively had a diagnostic accu-
racy of 84.8%.
Conclusions: Texture analysis improves diagnostic accuracy for differentiation
of benign andmalignant aswell as for benign and low-grade cartilaginous lesions
when compared with morphologic MRI analysis.
Key Words: cartilaginous neoplasms, enchondroma, chondrosarcoma,
texture analysis, quantitative analysis, magnetic resonance imaging
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C artilaginous neoplasms are characterized by the production ofchondroid matrix.1 Themajority of lesions are benign enchondromas,
which can be found with a prevalence of 2.9% and 2.1% on knee and
shoulder MRI examinations, respectively.2,3 Chondrosarcomas are less
common but represent the secondmost common sarcoma of the bonewith
an annual incidence of approximately 1:200,000.4,5
Based on histopathological criteria, chondrosarcomas can be cat-
egorized as grade 1 to 3, as well as into different subtypes including
dedifferentiated chondrosarcoma.1,6 Grade 1 chondrosarcomas are
low-grade tumors of intermediate malignancy with low rates of recur-
rence and metastatic spread, which can be treated with intralesional cu-
rettage and optional local adjuvant therapy.7–10 Grade 2, grade 3, and
dedifferentiated chondrosarcomas represent high-grade tumors with
high rates of recurrence, metastatic spread, and mortality, which usually
require surgical resection with wide margins and subsequent recon-
struction or amputation.11–15
Because the reliable differentiation and grading of cartilaginous
neoplasms can be a challenging task for radiologists and pathologists
due to the overlap of imaging features and histopathological criteria
of benign lesions and low-grade chondrosarcomas as well as low-
grade and high-grade chondrosarcomas,16–20 there is a need for more
accurate techniques.
Classic magnetic resonance imaging (MRI) is often used for
grading of cartilaginous neoplasms. Avariety ofMRI features assessing
tumor matrix, bone remodeling, and peritumoral tissue abnormalities
have been described16,21–24; however, their interreader reproducibility
and predictive values are to some extent unclear.24
Texture analysis is a novel objective biomarker for quantitative
tumor assessment, which has shown encouraging results in tumors of
the brain, lung, and liver.25–27 Texture analysis is a mathematical tech-
nique, which allows computerized quantification of image characteris-
tics based on the distribution of pixels or voxels and their intensities
within a defined region of interest (ROI). Although texture analysis
(TA) is typically applied to characterize the tumor matrix, peritumoral
abnormalities are usually not included in the analysis, although visible
onMRI scans. Therefore, a combined approach of morphologicMRI anal-
ysis and TA may show a complementary effect and potentially result in
higher diagnostic accuracies.We aimed to assess the interreader agreement
and diagnostic accuracy of MRI-based TA for grading of cartilaginous
bone tumors in comparison to standard morphologic MRI analysis.
MATERIALS AND METHODS
This retrospective single-center study was approved by our local
ethics committee.
Study Design and Patients
Patients with cartilaginous bone neoplasms who underwent
contrast-enhancedMRI were identified through a search of our hospital
and radiological information systems between January 2008 and
December 2016. Inclusion criteria were (1) enchondromas or periosteal
chondromas proven by histopathology (n = 16) or by a follow-up period
of minimum 5 years without alteration in size and shape accompanied
with typical imaging features of cartilaginous lesions including lobu-
lated texture and T2-weighted hyperintensity on MRI (n = 37);
Received for publication February 7, 2018; and accepted for publication, after revision,
April 17, 2018.
From the *Department of Radiology, Balgrist University Hospital; †Faculty of
Medicine, University of Zurich; ‡Department of Orthopedic Surgery, Balgrist
University Hospital; and §Institute of Diagnostic and Interventional Radiology,
University Hospital Zurich, Zurich, Switzerland.
The authors report no conflicts of interest.
Correspondence to: Benjamin Fritz, MD, Department of Radiology, Balgrist Uni-
versity Hospital, Forchstrasse 340, CH-8008 Zurich, Switzerland. E-mail:
benjamin.fritz@balgrist.ch.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0020-9996/18/0000–0000
DOI: 10.1097/RLI.0000000000000486
ORIGINAL ARTICLE
Investigative Radiology • Volume 00, Number 00, Month 2018 www.investigativeradiology.com 1
                                            Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.                                               
                                 This paper can be cited using the date of access and the unique DOI number which can be found in the footnotes.
(2) conventional central or periosteal chondrosarcomas grade 1–3 and
dedifferentiated chondrosarcoma proven by histopathology (n = 63);
(3) MRI of the cartilaginous neoplasm performed at a time interval of
maximum 6 months before biopsy, curettage, or surgery for tumors di-
agnosed by histopathology; and (4) contrast-enhanced MRI performed
on clinical 1.5 T or 3 T scanners, including at least sequences ac-
quired in 2 planes with T1-weighted (T1w) and contrast-enhanced
T1w fat-suppressed (CE-T1wfs) images as well as at least one addi-
tional fluid-sensitive fat-suppressed sequence. Exclusion criteria were
(1) chondroma or chondrosarcoma of the spine, rips, scull, hands, or
feet (n = 17); (2) extraskeletal chondrosarcoma (n = 5); (3) secondary
chondrosarcoma due to a preexisting cartilaginous lesion, that is, aris-
ing from enchondroma or osteochondroma (n = 6); (4) cartilaginous
bone neoplasms of patients with enchondromatosis (Ollier disease);
(5) pathological fracture in the area of the tumor (n = 4); (6) ambiguous
histopathology report (n = 6); (7) insufficient image quality of the MRI
(n = 6); and (8) locally recurrent chondrosarcoma (n = 4).
The final study population included 116 patients (62 women and
54 men) with a mean age of 48.8 ± 18.2 years (range, 15–88 years).
Sixty-eight patients (58.6%) underwent MRI at our institution and
48 patients (41.4%) underwent MRI at outside institutions. The carti-
laginous neoplasms consisted of 53 benign tumors (46 enchondromas
and 7 periosteal chondromas), 26 low-grade chondrosarcomas (20 con-
ventional chondrosarcomas and 6 periosteal chondrosarcomas), and 37
high-grade chondrosarcomas (24 grade 2/3 and 13 dedifferentiated
chondrosarcomas; 31 conventional chondrosarcomas and 5 periosteal
chondrosarcomas). The cartilaginous neoplasms were located in the fe-
mur (n = 38), humerus (n = 29), pelvis (n = 17), tibia (n = 15), scapula
(n = 9), fibula (n = 4), sternum (n = 2), radius (n = 1), and ulna (n = 1).
The study design consisted of a qualitative morphologic read-out
by 2 blinded expert musculoskeletal radiologists, who graded each le-
sion according to clinical routine and determined the presence of 14
common MRI features of cartilaginous bone tumors, as well as a quan-
titative assessment of tumor texture by 2 different musculoskeletal
radiologists (Fig. 1).
Histopathology
Histopathology reports were reviewed respectively for the final
diagnosis. At the time of diagnosis, the pathologists did not have elec-
tronic access to the MRI examinations of the patients, which were
stored in the picture archiving and communication system (PACS) of
a different institution. All included chondrosarcomas as well as 16
chondromas (all 7 periosteal chondromas and 9 enchondromas) were
diagnosed based on the presence of hyaline cartilage production and
classified according to cellularity, cellular atypia, myxoid change,
and mitotic figures as well as entrapment or destruction of trabecu-
lar bone.6,17,28,29 The remaining 37 enchondromas were proven by a
follow-up period of minimum 5 years without alteration of size and
shape. For the histopathologically proven chondrosarcomas and
chondromas, histopathologic diagnoses relied on resections of
the entire tumors. Cartilaginous tumors were classified as benign
for enchondromas and periosteal chondromas, as low-grade for
chondrosarcomas grade 1, and as high-grade for chondrosarcomas
grade 2, grade 3, and dedifferentiated chondrosarcomas.30
Morphologic MRI Analysis
Two experienced, fellowship-trained musculoskeletal radiolo-
gists (readers 1 and 2, C.W.A.P. and R.S.) with 18 and 12 years of expe-
rience in musculoskeletal radiology, respectively, evaluated the
anonymized studies separately on dedicated PACS workstations. The
readers were aware that all patients had a benign or malignant cartilag-
inous neoplasm but were blinded to any other information, including
the histopathological diagnosis, clinical course of the disease, and any
additional imaging study. In preparation for the study evaluation, both
readers underwent a joint training session on 15 caseswith cartilaginous
lesions that were not included in the study.
Readers were tasked to evaluate the studies for 14 MRI features
that have been described for the differentiation of cartilaginous bone
lesions16,21–24,31,32: (1) cortical thickening, defined as abnormal thick-
ening of the osseous cortex bordering the tumor in comparison to adja-
cent bone cortex without existing tumor interface; (2) scalloping of the
cortical bone, defined as a focal thinning of the osseous cortex by the
adjacent tumor; (3) cortical destruction, defined as a lytic or sclerotic
process destroying the integrity and continuity of the cortical bone;
(4) bone expansion, defined as focal distension and widening of the
bone diameter by the tumor mass without destruction of the cortical in-
tegrity; (5) active periostitis, defined as increased contrast enhancement
of the periosteum and/or focal thin fluid accumulation adjacent to the
periosteum; (6) bone marrow edema, defined as high signal intensity
on fluid-sensitive fat-suppressed images inside the bone with preserved
bone texture; (7) soft tissue edema, defined as high signal intensity on
fluid-sensitive fat-suppressed images of the tumor surrounding soft tis-
sue with or without contrast enhancement; (8) soft tissue mass, defined
as solid, extraosseous tumor mass with contrast enhancement replacing
or displacing physiological tissue; (9) internal septal or ring-and-arc en-
hancement, defined as an enhancement of scalloped and curvilinear
septa31,32; (10) lobular outer margin, defined as a lobular pattern of
the tumor boundary with contrast enhancement or fluid-like signal in-
tensity; (11) central nonenhancing portion, defined as a confluent re-
gion embedded inside the tumor lacking contrast enhancement; (12)
intralesional enhancing solid portion was defined as confluent tumor
tissue with marked homogenous enhancement; (13) fat inclusions were
defined as focal lesions with fat-like signal surrounded by tumor tissue.
Imaging features 1 to 13 were categorized on a binary scale into present
or absent. Feature 14 was the maximum tumor extent, which was
assessed by measuring the maximum tumor distance in millimeters in
any plane or sequence.
In addition, both readers were asked to grade the cartilaginous
neoplasms as benign, low grade, or high grade based on their impres-
sion after review of all available MRI sequences and rate their confi-
dence level on a scale from 0 to 10.
Texture Analysis
Based on the works of Vallières et al33 and Wei,34 a custom
Matlab-based software routine (Matlab; The MathWorks, Natick, MA)
FIGURE 1. Illustration of the study design. The 116 cartilaginous bone
lesions were analyzed in 4 different ways. Derived models and expert
diagnosis were compared using diagnostic accuracies represented by the
area under the of ROC analysis.
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was programmed in-house, that implemented a total of 19 different
2-dimensional (2D) TA features. The features consisted of 4 first-order pa-
rameters (variance, skewness, kurtosis, and entropy), 4 second-order pa-
rameters (gray-level co-occurrence matrix features: energy, contrast,
correlation, homogeneity), and 11 higher-order parameters (gray-level
run-length matrix features: short-run emphasis, long-run emphasis,
gray-level nonuniformity, run-length nonuniformity, run percentage,
low gray-level run emphasis, high gray-level run emphasis, short-
run low gray-level emphasis, short-run high gray-level emphasis,
long-run low gray-level emphasis, and long-run high gray-level em-
phasis) (see document, Supplemental Digital Content 1, for detailed
explanation and formulas).35–38
Two experienced, fellowship-trained musculoskeletal radiolo-
gists (reader 3 and 4, M.A.F. and B.F.) with 9 and 5 years of experience
in musculoskeletal radiology, respectively, performed the texture analy-
ses in an independent fashion. Readers selected the imagewith the larg-
est tumor dimension and imported the DICOM image to Matlab.
Preference was given to axial images; however, coronal images were
the second, and sagittal images were the third choice (Fig. 2). For dis-
tinction of solid tumor from peritumoral abnormalities, readers were
allowed to examine all available sequences of the MRI on the PACS
viewer. Next, readers segmented the tumor by drawing a free-hand
ROI along the tumor border on T1w and CE-T1wfs images. TheMatlab
algorithm automatically performed a normalization of the gray levels
and calculated all TA features based on the voxels inside the ROI.
Second- and higher-order features were calculated in 4 directions differ-
ing from each other in a 45-degree angle with subsequent calculation of
mean values for minimizing the relevance of the needed choice of
direction (Fig. 3).
Statistics
Statistical analyses were performed using SPSS version 21.0
(IBM, Chicago, IL) and MedCalc version 17.6 (MedCalc Software
bvba, Ostend, Belgium). General descriptive statistics were employed
with continuous data being reported as mean and standard deviations
and categorical data as proportions. Continuous data were tested for
normal distribution using the Kolmogorov-Smirnoff test. A 2-sided
P value of less than 0.05 was considered to represent significance.
Reader performances for grading of cartilaginous lesions were
determined by receiver operating characteristics (ROC) analysis with
the incorporation of the confidence levels. For measuring interreader re-
liability, we applied Cohen kappa for categorical data and intraclass cor-
relation coefficient (ICC) for continuous data.39 Kappa values were
considered to represent substantial/good agreement if 0.61 to 0.8 and al-
most perfect/very good agreement if greater than 0.8,40,41 and ICC
values were considered to represent good agreement if 0.6 to 0.74
and excellent agreement if 0.75 to 1.42 Associations of MRI features
and histological grades of cartilaginous neoplasms were tested using
the Fisher exact test for dichotomous data and the independent Student
t test for maximum tumor extent. Significant differences of TA features
FIGURE 2. A 60-year-old woman with an enchondroma of the proximal tibia. Sagittal STIR recovery (A) and axial contrast-enhanced T1w fat-saturated
(B) MRI scans showing typical septal and ring-and-arc enhancement (arrowheads) with subtle lobular outer margin (white arrows) and cortical scalloping
(black arrow) of the dorsal aspect of the tibia. Panel C shows the overlay of a free-hand ROI drawn on panel B, including the entire tumor as performed during
TA. Subsequently, the TA algorithm automatically performs cropping and intensity normalization of the tumor texture, as shown in panel D, allowing for
calculation of TA features (see Fig. 3).While 1 of the 2 expert readers graded this lesion incorrectly as chondrosarcoma grade I, TA graded this lesion correctly
as enchondroma.
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between histological grades of cartilaginous neoplasms were assessed
with the independent t test for parametric data and the Mann-Whitney
U test for nonparametric data. For further statistical analysis, mean
TAvalues of both readers (reader 3 and 4) and morphological features
rated by the senior reader were used.
To create a model for prediction of tumor grade, stepwise lo-
gistic regression analysis was performed separately and in combina-
tion (ratio of 1:1 between MRI and TA features) for significant and
reproducible (kappa or ICC value ≥ 0.6) MRI and TA features. To
avoid overfitting, a ratio of independent variable to cases was deter-
mined to be 1:10. In case of exceeding the number of independent
variables qualifying for inclusion into regression models, the fea-
tures with the lowest P values were selected. Models were calculated
with 5-fold cross-validation.
Independent predictors after regression analysis are reported
with odds ratios and 95% confidence intervals (CIs), P values, as well
as the regression coefficient and standard error. For each model, sensi-
tivity and specificity as well as the area under the curve (AUC) along
with the 95% CI received from ROC analysis were calculated. Differ-
ences between the models were calculated by comparison of the AUC
of the ROC curves according to the method of DeLong et al.43
RESULTS
Morphologic MRI Analysis
Expert Diagnosis
For reader 1 and for reader 2, the diagnostic accuracies repre-
sented by the AUC were 0.862 (95% CI, 0.793–0.932) and 0.904
(0.841–0.966) for differentiation of benign from malignant lesions,
0.810 (0.709–0.911) and 0.875 (0.799–0.951) for differentiation of
benign from low-grade lesions, and 0.785 (0.671–0.899) and 0.682
(0.545–0.820) for differentiation of low-grade from high-grade
lesions, respectively.
MRI Features
The frequency of the 14 MRI features and the interreader re-
liability according to histological tumor grades, as well as the dis-
crimination of benign versus malignant, benign versus low-grade,
and low-grade versus high-grade cartilaginous neoplasms are pre-
sented in Table 1. Significant MRI features of univariate analysis
with a kappa value ≥ 0.6 qualified as predictor variables for the re-
gression models (Table 1). Derived independent imaging features for
differentiation of benign from malignant, benign from low-grade, and
low-grade from high-grade lesions are given in Table 2. Diagnostic
accuracies represented by the AUC as well as sensitivities and
specificities are presented in Table 3.
Texture Analysis
Intraclass correlation coefficient between reader 3 and reader 4
was calculated for each of the 19 TA features on T1w and CE-T1wfs se-
quences separately, resulting in a mean ICC of 0.79 (standard deviation,
0.14; range, 0.43–0.99). In total, 18 TA features assessed on CE-T1wfs
images and 15 TA features assessed on T1w images had at least good
interobserver agreement with an ICC value of 0.6 or above. The mean
value of each TA feature from both readers was calculated and used
for analysis. Results of univariate analysis for differentiation of benign
from malignant and benign from low-grade cartilaginous lesions are
presented in Table 4. Therewere no significant TA features after univar-
iate analysis for differentiation of low-grade from high-grade lesions.
Only highly significant TA features of univariate analysis showing an
FIGURE 3. Illustration of the TA algorithm. First, tumor segmentation was performed by drawing a free-hand ROI along the border of the tumor
(column 1). Second, cropping and normalization of voxel gray levels inside the ROI was performed (column 2), as demonstrated by a simplifiedmatrix
containing gray levels ranging from 1 to 4. Third, histogram, gray level co-occurrence matrix, and gray level run-length matrix were calculated based
on the gray level distribution of voxels (column3). Examples of gray level co-occurrence and run-lengthmatrix (calculated in horizontal orientation) are
given in correspondence to the gray level matrix of column 2. Finally, first-order features were derived from the histogram, second-order features were
derived from the gray level co-occurrence matrix, and higher-order features were derived from the gray level run-length matrix (column 4).
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ICC value ≥ 0.6 were included as predictor variables into regression
models (Table 4). Derived independent TA features for discrimination
of benign from malignant and benign from low-grade lesions are
given in Table 2. The AUC, as well as sensitivities and specificities,
are given in Table 3. Additional performed subanalysis on 81 patients
that included T2w and short tau inversion recovery (STIR) images
into TA showed no additional increase of the diagnostic accuracy for
differentiation of benign from malignant, benign from low-grade, and
low-grade from high-grade cartilaginous neoplasms.
Combined TA and Morphologic MRI Analysis
Predictor models including both morphologic MRI features and
TA features were calculated similarly to the individual MRI or TA
feature analyses. The regression model for differentiation of benign
from malignant lesions included 5 MRI features and 5 TA features,
whereas the regression model for differentiation of benign from
low-grade lesions included 3 MRI features and 5 TA features
(Table 1 and 4). As no significant TA features existed after univariate
analysis for differentiation of low-grade from high-grade lesions, no
regression model was calculated. Derived independent MRI and TA
features for discrimination of benign from malignant and benign from
low-grade lesions are given in Table 2. The AUCs, as well as sensitivities
and specificities, are presented in Table 4 and Figure 4.
DISCUSSION
Accurate grading of cartilaginous bone neoplasms is of primary
clinical interest, because appropriate therapy differs significantly be-
tween different tumor grades, ranging from watchful waiting for benign
lesions, to intralesional curettage for low-grade chondrosarcoma, and
wide resection or amputation for high-grade chondrosarcoma. However,
both the radiological and histopathological grading of cartilaginous
bone neoplasms are difficult, as shown by the low reproducibility of
radiological and histopathological grading of 46 cartilaginous neo-
plasms by expert readers.19 Similarly, our study revealed a substantial
variability of diagnostic accuracies in the grading of cartilaginous
bone tumors by expert radiologists ranging from moderate to excel-
lent. Thus, objective quantitative biomarkers are desirable to improve
grading of cartilaginous neoplasms, especially for the clinically diffi-
cult but important task of differentiating between benign and low-
grade malignant lesions, as well as between low-grade and high-grade
malignant lesions19 (Fig. 5).
We analyzed the diagnostic value and interreader reproduc-
ibility of established MRI features for grading of cartilaginous
neoplasms.16,20–24,31,32,44 Similar to a previous study of Crim et al,24
our study showed a large overall variability of interreader agreement
for individual MRI features, which ranged from poor to excellent
(kappa value, 0.08–0.822). Limited interreader reproducibility of
some MRI features such as cortical thickening, cortical scalloping,
bone expansion, fat entrapment, lobular outer margin, or internal
septal or ring-and-arc enhancement may be caused by difficult and
ambiguous definitions.21,22,32,44
To establish a reproducible model for improved prediction of tu-
mor grades, we only included MRI features into the multivariate analy-
sis that had a kappa value of at least 0.6. Our models (Table 3) identified
in total 4 independent predictors for grading of cartilaginous neoplasms
consisting of bone marrow edema, soft tissue mass, maximum tumor
extent, and active periostitis. The latter was primarily important for
TABLE 1. Univariate Analysis of Association of MRI Features and Histological Tumor Grades
MRI Features
Benign
(n = 52)
Low Grade
(n = 27)
High Grade
(n = 37)
Malignant
(n = 64)
Benign vs
Low Grade (P)
Low Grade vs
High Grade (P)
Benign vs
Malignant (P) Kappa Value
1 Cortical thickening 4 (7.7%) 7 (25.9%) 3 (8.1%) 10 (15.6%) 0.039 0.081 0.256 0.193
2 Cortical scalloping 11 (21.2%) 11 (40.7%) 16 (43.2%) 27 (42.2%) 0.111 1 0.018 0.223
3 Cortical destruction*†‡§|| 10 (19.2%) 16 (59.3%) 32 (86.5%) 48 (75.0%) 0.001 0.019 <0.001 0.741
4 Bone expansion 5 (9.6%) 7 (25.9%) 4 (10.8%) 11 (17.2%) 0.95 0.179 0.287 0.35
5 Active periostitis*§|| 7 (13.5%) 9 (33.3%) 32 (86.5%) 41 (64.1%) 0.074 <0.001 <0.001 0.693
6 Reactive bone
marrow edema*†‡§||
4 (7.7%) 12 (44.4%) 30 (81.1%) 42 (65.6%) <0.001 0.003 <0.001 0.7
7 Reactive soft tissue edema *§|| 5 (9.6%) 7 (25.9%) 27 (73.0%) 34 (53.1%) 0.095 <0.001 <0.001 0.657
8 Soft tissue mass*†‡§ 8 (15.4%) 15 (55.6%) 30 (81.1%) 45 (70.3%) <0.001 0.051 <0.001 0.809
9 Internal septal or
ring-and-arc enhancement
48 (92.3%) 21 (77.8%) 27 (73.0%) 48 (75.0%) 0.082 0.774 0.015 0.434
10 Lobular outer margins 47 (90.4%) 25 (0,926) 26 (70.3%) 51 (79.7%) 1 0.033 0.13 0.388
11 Central nonenhancing portion 44 (84.6%) 22 (81.5%) 31 (83.8%) 53 (82.8%) 0.755 1 1 0.093
12 Intralesional enhancing
solid portion
35 (67.3%) 21 (77.8%) 33 (89.2%) 54 (84.4%) 0.436 0.3 0.046 0.149
13 Fat inclusion 16 (30.8%) 2 (7.4%) 1 (2.7%) 3 (4.7%) 0.023 0.568 <0.001 0.414
14 Maximum tumor extent, cm*|| 5.1 (SD 3.6) 6.2 (SD 3.6) 9.9 (SD 4.7) 8.3 (SD 4.6) 0.201 0.001 <0.001 0.99¶
Results of univariate analysis of the association of tumor grade and imaging features assessed by the senior expert reader as well as interreader reader reliability in
between both expert readers. Statistical significant P values are marked in bold print.
*Features included in the multivariate analysis for differentiation of benign and malignant lesions for the MRI feature model.
†Features included in the multivariate analysis for differentiation of benign and low-grade lesions for the MRI feature model.
‡Features included in the multivariate analysis for differentiation of benign and low-grade lesions for combined feature model.
§Features included in the multivariate analysis for differentiation of benign and malignant lesions for the combined feature model.
||Features included in the multivariate analysis for differentiation of low-grade and high-grade lesions.
¶Interreader reliability calculated using the intraclass correlation coefficient.
MRI indicates magnetic resonance imaging; SD, standard deviation.
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the diagnosis of high-grade neoplasms, which is in line with findings of
Douis et al.21 Compared with the grading based on expert readers'
impression, diagnostic accuracies of these prediction models were
superior for differentiation of low-grade from high-grade lesions but
similar or inferior for differentiation of benign from malignant or
benign from low-grade lesions. In comparison to published data, the
TABLE 2. Multivariate Analysis
Compared
Tumor Grades
Independent Predictors
(MRI Sequence)
Odds Ratio
(95% CI) P
Coefficient
(Standard Error)
MRI feature model Benign vs malignant Reactive bone marrow edema 14.305 (4.257–48.064) <0.001 2.661 (0.618)
Soft tissue mass 7.702 (2.731–21.722) <0.001 2.041 (0.529)
Constant 0.236 <0.001 −1.443 (0.342)
Benign vs low-grade Reactive bone marrow edema 6.312 (1.632–24.407) 0.008 1.842 (0.690)
Soft tissue mass 4.675 (1.477–14.795) 0.009 1.542 (0.588)
Constant 0.208 <0.001 −1.572 (0.361)
Low-grade vs high-grade Active periostitis 12.066 (3.127–46.562) <0.001 2.490 (0.689)
Maximum tumor extent 1.234 (1.042–1.461) 0.015 0.210 (0.086)
Constant 0.053 0.001 −2.931 (0.922)
TA feature model Benign vs malignant Skewness (T1w) 0.245 (0.111–0.539) <0.001 −1.406 (0.402)
Gray-level nonuniformity (T1w) 0.975 (0.956–0.995) 0.014 −0.025 (0.010)
Run-length nonuniformity (T1w) 1.001 (1.001–1.002) 0.001 0.001 (0.0005)
Constant 0.325 0.014 −1.124 (0.455)
Benign vs low-grade Short-run high gray-level emphasis (CE) 0.965 (0.934–0.997) 0.032 −0.036 (0.017)
Skewness (T1w) 0.180 (0.063–0.513) 0.001 −1.713 (0.533)
Gray-level nonuniformity (T1w) 0.971 (0.946–0.996) 0.024 −0.030 (0.013)
Run-length nonuniformity (T1w) 1.001 (1.0003–1.003) 0.009 0.001 (0.001)
Constant 4.012EXP16 0.038 38.213 (18.454)
Combined model Benign vs malignant Reactive bone marrow edema 12.42 (3.2–48.208) <0.001 2.519 (0.692)
Skewness (T1w) 0.39 (0.169–0.900) 0.027 −0.942 (0.427)
Gray-level nonuniformity (T1w) 0.978 (0.955–1.003) 0.078 −0.022 (0.012)
Run-length nonuniformity (T1w) 1.001 (1.0002–1.002) 0.015 0.001 (0.001)
Constant 0.168 0.001 −1.786 (0.555)
Benign vs low-grade Reactive bone marrow edema 16.235 (2.613–100.89) 0.003 2.787 (0.932)
Short-run high gray-level emphasis (CE) 0.942 (0.907–0.978) 0.002 −0.060 (0.019)
Skewness (T1w) 0.339 (0.115–0.997) 0.049 −1.082 (0.550)
Energy (T1w) 3.4 EXP−67 (0–3.9EXP + 16) 0.070 −475.311 (262.005)
Constant 6.844EXP28 0.001 66.396 (20.812)
Results of multivariate analysis for all regression models. Note that no significant TA features for differentiation of low-grade from high-grade chondrosarcoma
existed, therefore no TA- or combined-regression model was calculated. TA features are represented with the respective sequence in parentheses.
MRI indicates magnetic resonance imaging; CI, confidence interval; CE, contrast-enhanced T1-weighted fat-saturated sequence; T1w, T1-weighted sequence.
TABLE 3. ROC Analysis Results for Regression Models and Reader Impressions
Tumor Grade
MRI
Feature Model
TA Feature
Model
Combined
Model MRI vs TA
TAvs
Combined
MRI vs
Combined
Benign vs malignant Sensitivity 85.9% 81.3% 82.8%
Specificity 80.8% 90.4% 88.5%
AUC (95% CI) 0.870 (0.795–0.925) 0.898 (0.828–0.946) 0.929 (0.866–0.968) P = 0.458 P = 0.070 P = 0.034
Benign vs low-grade Sensitivity 70.4% 77.8% 74.1%
Specificity 80.8% 90.4% 88.5%
AUC (95% CI) 0.774 (0.666–0.861) 0.895 (0.806–0.953) 0.912 (0.827–0.964) P = 0.038 P = 0.363 P = 0.008
Low-grade vs high-grade Sensitivity 91.9% NA NA
Specificity 70.1% NA NA
AUC (95%-CI) 0.848 (0.736–0.925) NA NA
Statistical significant P values are marked in bold print.
MRI indicates magnetic resonance imaging; TA, texture analysis; CI, confidence interval; ROC, receiver operating characteristics; AUC, area under the curve;NA, not
applicable.
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diagnostic accuracies of our predictor models are lower for differentiation
of low-grade from high-grade chondrosarcoma21,22 and for the
differentiation of benign from malignant lesions,44 when compared
with reported diagnostic accuracies of 95.6% and 93.4%, respectively.
The differences might be explained by different study protocols, as
previous studies did not take into consideration the interreader
reliability of MRI features21,22 or performed additional dynamic
contrast-enhanced MRI.44
Texture analysis showed excellent robustness between both
readers as indicated by an excellent mean ICC value of 0.79, which
was substantially higher than the interreader reliability of morphologic
analysis of MRI imaging features and comparable to previously re-
ported data.45 Analogous to the morphologic MRI analysis, only signif-
icant texture features of univariate analysis with ICC values of 0.6 or
above were included in regression models.
In comparison to the morphologic MRI feature analysis, the di-
agnostic accuracies of 89.8% of the TA model for the differentiation
of benign from malignant lesions were only slightly higher without sta-
tistical significance, whereas the diagnostic accuracies of 89.5% of the
TAmodel for the differentiation of benign from low-grade cartilaginous
lesions were significantly superior.
A recent publication evaluating the diagnostic value of
3-dimensional (3D)–based TA for differentiation of enchondroma from
low-grade chondrosarcoma on 22 patients also found significant differ-
ences between TA features after univariate analysis.46 However, in
TABLE 4. Univariate Analysis of Association of TA Features and
Histological Tumor Grades
CE-T1wfs T1w
Benign vs
malignant
Contrast (P < 0.001)* Variance (P = 0.005)
Correlation (P < 0.001)* Skewness (P < 0.001) *†
Energy (P = 0.045) Kurtosis (P = 0.026)‡
Homogeneity (P < 0.001)* Energy (P < 0.001)
Entropy (P < 0.001)‡ GLN (P < 0.001)*†
SRE (P < 0.001)* RLN (P < 0.001)*†
LRE (P = 0.004) LGRE (P = 0.006)
GLN (P < 0.001)*† SRLGE (P = 0.007)
RLN (P < 0.001)* LRLGE (P = 0.019)
RP (P < 0.001)*
SRHGE (P < 0.001)*†
LRHGE (P = 0.002)
Benign vs
low-grade
Contrast (P = 0.035) Variance (P = 0.010)*†
Correlation (P = 0.044) Skewness (P < 0.001)*†
Homogeneity (P = 0.020)* Energy (P = 0.001)*†
Entropy (P = 0.034)‡ GLN (P = 0.015)*
SRE (P = 0.024) RLN (P = 0.006)*†
GLN (P = 0.027) LGRE (P = 0.021)*
RLN (P = 0.044) SRLGE (P = 0.025)
RP (P = 0.043)
SRHGE (P = 0.002)*†
LRHGE (P = 0.029)
Low-grade vs
high-grade
No significant TA features No significant TA features
Results of univariate analysis demonstrating TA features with P < 0.05 for
differentiation of benign from malignant, benign from low-grade, and low-grade
from high-grade cartilaginous neoplasms.
*Features included in TA multivariate regression analysis.
†Features included in combined multivariate regression analysis with both
MRI and TA features.
‡TA features with an ICC < 0.6.
TA indicates texture analysis; CE-T1wfs, contrast-enhanced T1-weighted
fat-suppressed; T1w, T1-weighted; SRE, short-run emphasis; LRE, long-run
emphasis; GLN, gray-level nonuniformity; RLN, run-length nonuniformity;
RP, run percentage; LGRE, low gray-level run emphasis; SRLGE, short-run
low gray-level emphasis; SRHGE, short-run high gray-level emphasis; LRHGE,
long-run high gray-level emphasis; LRLGE, long-run low gray-level emphasis.
FIGURE 4. Receiver operating characteristic analysis of each regression
model for differentiation of (A) benign from malignant cartilaginous
neoplasms and (B) benign from low-grade cartilaginous neoplasms. The
AUC was highest for the combined model of MRI and TA features
(yellow line) as compared with the MRI feature only (blue line) and TA
feature only model (green line), showing an AUC of 0.929 and
0.912, respectively.
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contrast to our results, the authors found significant differences for en-
tropy on T1w images and for kurtosis and skewness on CE-T1wfs im-
ages. On the other hand, the significant TA features of our study were
either not statistically significant or not evaluated in the mentioned
study. These differences might relate to differences for 3D and 2D anal-
ysis or to differences for calculating the texture features, which were not
described in the published study. Furthermore, our study implemented 2
readers who performed TA compared with one reader of the previous
study and included a larger number of patients on each subgroup, which
also may explain for differences in between both studies.
Similar to our study, recent publications also showed an additive
value of TA and, in general, of computer-aided diagnostics, for the as-
sessment of neoplasms and nonneoplastic conditions in other parts of
the body, such as the brain, lung, gastrointestinal tract, or the
heart.25,26,47–50 Interestingly, the significant and independent TA features
for grading of cartilaginous lesions in our study were partly overlapping
with independent TA features of other tumor entities such as run-length
nonuniformity in glioblastoma,25 lipoma, and liposarcoma,51 as well as
skewness in renal cell carcinoma.52 However, several other TA features
differed substantially between recent TA studies evaluating malignan-
cies,26,45,53 probably reflecting the biological and histopathological dif-
ferences of various neoplasms.
To further improve diagnostic accuracies, we combinedmorpho-
logic MRI and TA features allowing to compete for inclusion into re-
gression models. Our results show a complementary effect of both
techniques resulting in the highest diagnostic accuracies of 92.9% for
differentiation of benign from malignant and 91.2% for differentiation
of benign from low-grade lesions, which were statistically significantly
higher in comparison to the morphologic MRI feature models for both
analyses. The increase of diagnostic accuracies compared with separate
morphologicMRI analysis or separate TA is predominately based on an
improved diagnostic accuracy for differentiation of benign cartilaginous
lesions from low-grade chondrosarcomas, which is likely explained by
the fact that TA evaluated the actual tumor structure, whereas included
MRI features assessed the surrounding tumor abnormalities. The diag-
nostic accuracies of our combined model are overall among the highest
reported in the literature for MRI-based grading of cartilaginous neo-
plasms.16,21,22,24,32,44,54 Importantly, diagnostic accuracy of the com-
bined model of 91.2% for differentiation of benign from low-grade
lesions is higher than previously reported24,54 and the diagnostic accu-
racies of our expert reader assessment, underlining the added value of
TA even for the experienced musculoskeletal radiologist.
For differentiation of benign from malignant cartilaginous
neoplasms, the diagnostic accuracy of 92.9% of the combined
model of our study is similar to results of studies of De Coninck
et al,44 who reported a diagnostic accuracy of 93.4% using dynamic
contrast-enhanced MRI, and Murphey et al16 of a statistical analysis
of multimodality imaging with radiography, computed tomography,
and MRI. In contrast, our study also included a relevant proportion
of periosteal lesions and dedifferentiated chondrosarcoma, reflecting al-
most the entire spectrum of cartilaginous neoplasms. Nevertheless, be-
cause cartilaginous neoplasms of the hands and feet are most likely
benign and cartilaginous neoplasms of the spine, rips, and scull are
most likely malignant, we excluded these patients, because assessments
purely based on tumor location rather than MRI morphology could
have influenced results significantly. In addition to dynamic
contrast-enhanced MRI, diffusion-weighted imaging is another func-
tional MRI technique that is frequently employed for tumor imaging,
which, however, does not aid in the differentiation and grading of
cartilaginous neoplasms.55
A large variety of TA features have been proposed and published
relying on either histogram analysis or on analysis of specific matrixes,
such as the co-occurrence matrix or the gray-level run-length matrix as
implemented in our study. We evaluated a total of 19 texture features
consisting of 5 first-order features and of 14 second- or higher-order
features, which we applied on both T1w and on fat-saturated contrast-
enhanced T1w images. First-order features rely on histogram analysis
describing the gray-level distribution of an image. As an example, the
first-order feature variance describes the width of the histogram and
measures the deviation of gray levels from the mean. The first-order
feature skewness, which was an independent predictor of our study,
measures the asymmetry of the histogram in relation to the mean, de-
scribing if the histogram has a tail to lower or higher intensities. En-
tropy, on the other hand, describes the irregularity of gray-level
distributions and is considered as a measure of heterogeneity. In con-
trast to first-order features, second-order features and higher-order
features are more complex and describe not only voxel intensities
but give information about their spatial distribution. Although some
attempts have been made to link these features to tissue microenviron-
ment,53 second- and higher-order features are mostly accepted to be
statistical representations of texture patterns not appreciable be standard
morphologic image interpretation without further knowledge of their
microenvironmental counterparts.56–58
Our study has limitations. First, this study was performed ret-
rospectively, which did not allow for the use of dynamic contrast-
enhanced MRI or a multimodality approach.16,44 However, a recent
study stated that dynamic contrast-enhancedMRI is not useful for dif-
ferentiation of enchondroma from low-grade chondrosarcoma.59
Nevertheless, we achieved similar to higher diagnostic accuracies,
whereas focusing on reproducibility of both our calculated models
as well as included imaging sequences. Although we performed
cross-validation of the calculated models, prospective verification of
our study results would further underline the value of TA for grading
of cartilaginous neoplasms. Second, we did not include additional TA
on T2w or STIR images because those sequences were not available
in all patients. However, our subanalysis did not suggest additional
improvements in diagnostic accuracies through the addition of T2w-
or STIR-based TA features. Third, we used a 2D approach for TA, by
selecting the imagewith the largest tumor area. This decision was based
on studies suggesting that 2DTA is noninferior to 3DTA.60 In addition,
2D TA is a more clinical applicable approach in comparison to 3D TA,
because ROI definition can be achieved much faster. Finally, histopath-
ological diagnosis, which was used as the standard of reference in our
study, may be influenced by substantial interreader variability19 and
FIGURE 5. An 18-year-old man with high-grade chondrosarcoma of the
medial femoral condyle. A, Coronal STIR MRI scan shows extensive
bone marrow edema (asterisks) surrounding the tumor and a thin fluid
accumulation along the cortical bone (arrowhead) representing
periostitis. B, Contrast-enhanced T1w fat-saturated MRI scan shows
corresponding marked contrast enhancement of the periosteum
adjacent to the tumor (arrows), suggesting periostitis. One reader graded
this lesion as a low-grade chondrosarcoma, whereas the other reader,
as well as the MRI feature model, graded this lesion correctly as a
high-grade chondrosarcoma. Texture analysis, in comparison, did not
show a benefit for differentiation of low-grade from high-grade
chondrosarcoma.
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therefore may have influenced our results. Furthermore, in some cases,
histopathological diagnoses were influenced by imaging data because
selected cases were discussed in multidisciplinary conferences by pa-
thologists and radiologists. Although this is common practice and there-
fore inevitable, histopathology may not be considered as a truly
independent standard of reference for morphological MRI analyses in
all cases, possibly leading to an overestimation of diagnostic accuracies
based on morphological MRI analyses.
In conclusion, TA improves diagnostic accuracy for differentia-
tion of benign and malignant as well as for benign and low-grade carti-
laginous lesions when compared with morphologic MRI analysis.
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